Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function.

Conclusion: Cystatin C may be an independent predictor of metabolic syndrome and therefore valuable for management of NSTE-ACS patients. Further multicenter, large-scale studies are required to assess the implication of these results. PMID: 31317040 [PubMed - indexed for MEDLINE]

https://www.ncbi.nlm.nih.gov/pubmed/31317040?dopt=Abstract

Source: Biomed Res - December 21, 2019 Category: Research Authors: Mao Q, Zhao N, Wang Y, Li Y, Xiang C, Li L, Zheng W, Xu S, Zhao XH Tags: Biomed Res Int Source Type: research